简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

CureVac, TELUS International, Oracle And Other Big Stocks Moving Higher On Thursday

2025-06-12 22:50

U.S. stocks were higher, with the Dow Jones index gaining around 0.1% on Thursday.

Shares of CureVac N.V. (NASDAQ:CVAC) rose sharply during Thursday's session after BioNTech announced it will acquire the company in an all-stock transaction.

CureVac shares jumped 38% to $5.61 on Thursday.

Here are some other big stocks recording gains in today’s session.

  • TELUS International (Cda) Inc. (NASDAQ:TIXT) gained 20.6% to $3.57 after the company announced it proposed the acquisition of TELUS Digital to accelerate AI and SaaS transformation across core business sectors.
  • Fortrea Holdings Inc. (NASDAQ:FTRE) jumped 15% to $6.25. Fortrea adopted limited-duration stockholder rights plan.
  • Oracle Corporation (NYSE:ORCL) gained 13.7% to $200.65 after the company reported better-than-expected quarterly financial results and issued upbeat outlook commentary.
  • Hippo Holdings Inc. (NYSE:HIPO) rose 13.1% to $30.64. The Baldwin Group entered into agreement to acquire Homebuilder Distribution Network from Hippo.
  • USA Rare Earth, Inc. (NASDAQ:USAR) climbed 12.8% to $14.05.
  • DeFi Development Corp. (NASDAQ:DFDV) gained 11.7% to $29.34. The company announced it secured a $5 billion equity facility with RK Capital.
  • Yuanbao Inc. (NASDAQ:YB) rose 11.7% to $17.58.
  • TransAlta Corporation (NYSE:TAC) gained 7.4% to $11.25. Jefferies analyst Julien Dumoulin-Smith upgraded TransAlta from Hold to Buy and raised the price target from C$12 to C$20.
  • Genius Sports Limited (NYSE:GENI) rose 6.5% to $10.28. Texas Capital Securities analyst David Bain initiated coverage on Genius Sports with a Buy rating and announced a price target of $14.
  • BeOne Medicines Ltd. (NASDAQ:ONC) rose 6% to $277.93 after the company announced that the FDA approved a new tablet formulation of BRUKINSA for all five approved indications.

Now Read This:

  • Top 2 Defensive Stocks That May Keep You Up At Night In Q2

Photo via Shutterstock

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。